ENDRA Life Sciences (NDRA) Cost of Revenue: 2016-2024
Historic Cost of Revenue for ENDRA Life Sciences (NDRA) over the last 9 years, with Dec 2024 value amounting to $571,040.
- ENDRA Life Sciences' Cost of Revenue rose 98.58% to $382,113 in Q4 2021 from the same period last year, while for Dec 2021 it was $1.1 million, marking a year-over-year increase of 84.81%. This contributed to the annual value of $571,040 for FY2024, which is 30.41% down from last year.
- ENDRA Life Sciences' Cost of Revenue amounted to $571,040 in FY2024, which was down 30.41% from $820,554 recorded in FY2023.
- ENDRA Life Sciences' Cost of Revenue's 5-year high stood at $1.4 million during FY2022, with a 5-year trough of $571,040 in FY2024.
- In the last 3 years, ENDRA Life Sciences' Cost of Revenue had a median value of $820,554 in 2023 and averaged $940,248.
- Its Cost of Revenue has fluctuated over the past 5 years, first spiked by 84.81% in 2021, then tumbled by 42.58% in 2023.
- Yearly analysis of 5 years shows ENDRA Life Sciences' Cost of Revenue stood at $581,893 in 2020, then skyrocketed by 84.81% to $1.1 million in 2021, then surged by 32.90% to $1.4 million in 2022, then crashed by 42.58% to $820,554 in 2023, then crashed by 30.41% to $571,040 in 2024.